SecSonar.com

RedHill Biopharma Ltd. (RDHL)

RedHill Biopharma Ltd. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

RedHill Biopharma Ltd. (RDHL) is a Drug Manufacturers - Specialty & Generic company based in IL with a market capitalization of $3.1M. Revenue declined 96.4% year-over-year and free cash flow was negative at -$9.7M. This page tracks RDHL's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

IL · 35 employees · IPO Jan 7, 2013

Valuation

Valuation & price

$1.03 · as of May 17, 2026 · -59.1% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

0.72

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$2.42$1.58$0.75Jul 25Dec 25Jul 26Jul 7, 25$2.06Jul 9, 25$2.09Jul 11, 25$2.19Jul 15, 25$1.91Jul 17, 25$2.42Jul 21, 25$2.35Jul 23, 25$2.02Jul 25, 25$1.71Jul 29, 25$1.48Jul 31, 25$1.31Aug 4, 25$1.21Aug 6, 25$1.23Aug 11, 25$1.27Aug 13, 25$1.39Aug 15, 25$1.36Aug 19, 25$1.45Aug 21, 25$1.30Aug 25, 25$1.37Aug 27, 25$1.33Aug 29, 25$1.35Sep 3, 25$1.28Sep 5, 25$1.43Sep 9, 25$1.42Sep 11, 25$1.60Sep 16, 25$1.52Sep 18, 25$1.70Sep 22, 25$1.67Sep 24, 25$1.67Sep 26, 25$1.84Sep 30, 25$2.17Oct 2, 25$2.22Oct 6, 25$1.99Oct 8, 25$1.82Oct 10, 25$1.70Oct 14, 25$1.61Oct 16, 25$1.57Oct 21, 25$1.80Oct 23, 25$1.73Oct 27, 25$1.57Oct 29, 25$1.46Oct 31, 25$1.30Nov 4, 25$1.08Nov 6, 25$1.16Nov 10, 25$1.07Nov 12, 25$1.07Nov 14, 25$1.07Nov 18, 25$1.06Nov 20, 25$1.04Nov 25, 25$1.11Nov 28, 25$1.20Dec 2, 25$1.19Dec 4, 25$1.20Dec 8, 25$1.19Dec 10, 25$1.22Dec 12, 25$1.21Dec 16, 25$1.21Dec 18, 25$1.15Dec 22, 25$1.15Dec 24, 25$1.15Dec 29, 25$1.09Jan 2, 26$1.03Jan 6, 26$1.37Jan 8, 26$1.34Jan 12, 26$1.27Jan 14, 26$1.23Jan 16, 26$1.36Jan 21, 26$1.35Jan 23, 26$1.36Jan 27, 26$1.33Jan 29, 26$1.27Feb 2, 26$1.15Feb 4, 26$1.06Feb 9, 26$1.06Feb 11, 26$0.96Feb 13, 26$1.00Feb 18, 26$0.99Feb 20, 26$0.98Feb 24, 26$0.99Feb 26, 26$0.98Mar 2, 26$0.93Mar 4, 26$0.94Mar 6, 26$0.92Mar 10, 26$0.90Mar 12, 26$0.88Mar 17, 26$0.88Mar 19, 26$0.89Mar 23, 26$0.87Mar 25, 26$0.89Mar 27, 26$0.75Mar 31, 26$0.75Apr 2, 26$0.80Apr 7, 26$0.80Apr 9, 26$0.83Apr 13, 26$0.81Apr 15, 26$0.81Apr 17, 26$0.80Apr 22, 26$0.85Apr 24, 26$1.02Apr 28, 26$1.04Apr 30, 26$1.09May 4, 26$1.04May 6, 26$1.02May 8, 26$1.01May 12, 26$1.02May 14, 26$1.02May 18, 26$0.93May 20, 26$0.92May 22, 26$0.98May 28, 26$1.00Jun 1, 26$1.00Jun 3, 26$1.00Jun 5, 26$1.03Jun 9, 26$0.80Jun 11, 26$0.92Jun 15, 26$0.83Jun 17, 26$0.79Jun 22, 26$0.84Jun 24, 26$0.91Jun 26, 26$0.88Jul 2, 26$0.81
$0.7452-week range$2.52
Loading valuation history…

Fundamentals

Key fundamentals

$3.1M

Market cap

-96.4%

Revenue growth (YoY)

100.0%

Gross margin

-$9.7M

Free cash flow (USD)

-$2.9M

Net debt

Net cash position

28.2%

Share dilution

3/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$101.0KFY 2017$4.0MFY 2018$8.4MFY 2019$6.3MFY 2020$64.4MFY 2021$85.8MFY 2022$61.8MFY 2023$6.5MFY 2024$8.0MFY 2025$286.0K
$101K$286K

Free cash flow by year

2016 → 2025

FY 2016$-28.4MFY 2017$-46.0MFY 2018$-34.5MFY 2019$-41.0MFY 2020$-102.4MFY 2021$-65.2MFY 2022$-29.4MFY 2023$-35.8MFY 2024$-9.4MFY 2025$-9.7M
-$28.4M-$9.7M

Gross margin by year

2021 → 2025

FY 202142.4%FY 202246.1%FY 202347.0%FY 202460.3%FY 2025100.0%
42.4%100.0%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

1

Insider sells · 90 days

Earnings

Last report: 6-K filed Apr 27, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 6-K filingAnnual General Meeting RescheduledJul 1, 2026Filing
  • 6-K filingCapital RaiseJun 29, 2026Filing
  • 6-K filingAnnual General Meeting NoticeJun 25, 2026Filing
  • 6-K filingAnnual General Meeting NoticeJun 22, 2026Filing
  • 6-K filingSecurities Purchase AgreementJun 22, 2026Filing
  • 6-K filingPrivate Placement AnnouncementJun 22, 2026Filing
  • 6-K filingPrivate Placement AnnouncementJun 18, 2026Filing
  • 6-K filingFDA Designation ReceivedJun 9, 2026Filing
  • 6-K filingLegal Judgment EnforcementJun 8, 2026Filing
  • 6-K filingRegulatory UpdateJun 2, 2026Filing

Questions

Frequently asked questions

What is RedHill Biopharma Ltd.'s market cap?

RedHill Biopharma Ltd. (RDHL) has a market capitalization of $3.1M.

What is RDHL's P/E ratio?

A meaningful P/E ratio is not available for RDHL — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is RDHL's price-to-book (P/B) ratio?

RDHL trades at 0.72 times book value per share.

Are insiders buying RDHL stock?

SEC Form 4 filings show no open-market insider buys at RedHill Biopharma Ltd. in the last 90 days (1 sell).

Same arena

Related companies in Drug Manufacturers - Specialty & Generic

CPHI

China Pharma Holdings, Inc.

$2.4M

GELS

Gelteq Limited Ordinary Shares

$4.1M

SNOA

Sonoma Pharmaceuticals, Inc.

$2M

UPC

Universe Pharmaceuticals Inc.

$1.8M

SBFM

Sunshine Biopharma, Inc.

$1.4M

SXTC

China SXT Pharmaceuticals, Inc.

$1.3M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.